DUBLIN--(BUSINESS WIRE)--The "Global
Nebulizer Market - By Type and Geography - Growth, Trends, and Forecast
(2018 - 2023)" report has been added to ResearchAndMarkets.com's
offering.
The nebulizer market is expected to register a CAGR of about 6.5%,
during the forecast period.
Rising incidence of chronic respiratory diseases, increasing demand for
home healthcare devices, and rising geriatric population base are among
the key factors driving market growth.
Increasing Demand for Home Healthcare Devices
The geriatric population is rising steadily. As aging is associated with
the weakening of immune system, making an individual susceptible to
diseases, the demand for home healthcare devices, such as nebulizers,
inhalers, and glucose monitoring devices is expected to swell. Though
all age groups use nebulizers for drug delivery for the treatment of
respiratory diseases, people aged 60 and above prefer them the most due
to the devices feasibility in home care.
Since, many people shifted from hospital care to home care-based
treatment, which has helped them take an active role in managing their
diseases. They can opt for devices that allow better diagnosis and
treatment of diseases from the comfort of their homes. These devices are
easily available and are comfortable and easy to use. This shift led to
the development of portable nebulizers. People use these devices for
aerosol therapy at home, thus reducing the need for hospital stays. This
trend will help in boosting the growth of the nebulizer market.
Other factors that will affect the growth of the nebulizer market
include; rising incidence of chronic respiratory diseases and rising
geriatric population base.
Other Highlights
-
Drug Loss during Drug Delivery
-
North America to Dominate the Market
Key Development in the Market
-
Tyvaso was approved by the FDA for the treatment of PAH in 2009, as a
new drug-device combination product. This included Tyvaso plus an
ultrasonic nebulizer and accessories - referred to as the Tyvaso
Inhalation System.
Companies Featured
-
Omron Corporation
-
Koninklijke Philips N.V.
-
Pari Pharma
-
Allied Healthcare Products Inc.
-
Becton, Dickinson & Company
-
Agilent Technologies
-
Medline Industries Inc.
-
Briggs Healthcare
-
Drive Medical
-
GF Health Products Inc.
Key Topics Covered
1. Introduction
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Market Dynamics
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/l2pcfr/global_nebulizer?w=4
